GlassScriptPhysician profile
Gabriel Cathcart
NPI 1518526193
$689.07
in general payments reported to CMS, 2019-2025
8 companies · $555 in 2025
The $555 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $134 · 2025: $555.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $649 · Travel and Lodging: $40.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $648.57 |
| Travel and Lodging | $40.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $317.05 | 2024-2025 | |
| Kuros Biosciences USA, INC | $248.11 | 2025 | Magnetos |
| Orthofix Medical, INC. | $30.20 | 2025 | Accelstim |
| Bioventus LLC | $28.68 | 2024 | Exogen Ultrasound Bone Healing System |
| Ibsa Pharma INC. | $19.83 | 2024 | Licart, Tirosint |
| Amgen INC. | $17.46 | 2024 | Krystexxa |
| Innovation Technologies INC | $15.05 | 2024 | Irrisept |
| Reprise Biomedical, INC. | $12.69 | 2024 | Miro3d |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gabriel Cathcart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.